Vermillion Wealth Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Vermillion Wealth Management's ELV Position: Q2 2026 in Review
Vermillion Wealth Management reduced its Elevance Health (ELV) stake by 12% in Q2 2026, selling an estimated $2.6K and leaving 52 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #912.
Vermillion Wealth Management first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $21.9K in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Vermillion Wealth Management held 52 shares of Elevance Health worth $20K as of Q2 2026.
- Vermillion Wealth Management sold 7 Elevance Health shares in Q2 2026, an estimated $2.6K.
- Elevance Health made up ﹤0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #912 holding.
- Vermillion Wealth Management first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
- Vermillion Wealth Management's Elevance Health position peaked at $21.9K in Q1 2025.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.